Skip to content

Zoetis ZTS Fish — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Animal health diagnostics
$117M+12.5%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Contract manufacturing & human health
$23M-23.3%
Sheep and other
$17M+6.3%

Similar metrics at other companies

Elanco Animal Health Inc. logo
ELANFarm Animal: — Revenue
$642M+17.6%
Johnson Outdoors logo
JOUTFishing — Net Sales
$159.03M+17.9%
Johnson Outdoors logo
JOUTFishing — Acquisition
$0
HWK
HWKNFood — Revenue
$1.37M+8.4%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%
HWK
HWKNFood and Health Sciences — Revenue
$80.18M-0.6%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's fish — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's fish — revenue?
Zoetis (ZTS) reported fish — revenue of $66M in Q1 2026.
How has Zoetis's fish — revenue changed year-over-year?
Zoetis's fish — revenue increased by 20.0% year-over-year, from $55M to $66M.
What is the long-term trend for Zoetis's fish — revenue?
Over 4 years (2021 to 2025), Zoetis's fish — revenue has grown at a 11.4% compound annual growth rate (CAGR), from $187M to $288M.
What does fish — revenue mean?
This metric represents the total gross sales generated from the company's portfolio of health products specifically designed for the aquaculture and fish farming industry. It encompasses revenue from vaccines, parasiticides, and other therapeutic treatments used to manage the health and productivity of farmed aquatic species. This segment reflects the company's exposure to the global aquaculture market and its ability to capture demand for specialized aquatic health solutions.